BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Suzuki S, Esaki M, Kusano C, Ikehara H, Gotoda T. Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance? World J Gastroenterol 2019; 25(16): 1907-1912 [PMID: 31086459 DOI: 10.3748/wjg.v25.i16.1907]
URL: https://www.wjgnet.com/1007-9327/full/v25/i16/1907.htm
Number Citing Articles
1
Vladimir Milivojevic, Tomica Milosavljevic. Burden of Gastroduodenal Diseases from the Global PerspectiveCurrent Treatment Options in Gastroenterology 2020; 18(1): 148 doi: 10.1007/s11938-020-00277-z
2
Najmeh Salehi, Bahareh Attaran, Fatemeh Zare‐Mirakabad, Bahareh Ghadiri, Maryam Esmaeili, Mohadeseh Shakaram, Mohammad Tashakoripour, Mahmoud Eshagh Hosseini, Marjan Mohammadi. The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains Helicobacter 2020; 25(6) doi: 10.1111/hel.12731
3
Pei‐Ying Zou, Jie Hu, Jing‐Tao Zhao, Zhe Zhao, Hao Mei, Jing Yang, Yang‐Jie Zhu, Yi Zhang, Chun‐Hui Lan. 10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori : A propensity score matching analysis Helicobacter 2021; 26(5) doi: 10.1111/hel.12833
4
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategiesCritical Reviews in Microbiology 2021; : 1 doi: 10.1080/1040841X.2021.1975643
5
Lyudmila Boyanova, Rumyana Markovska, Petyo Hadzhiyski, Nayden Kandilarov, Ivan Mitov. Rifamycin use for treatment of Helicobacter pylori infection: a review of recent dataFuture Microbiology 2020; 15(12): 1185 doi: 10.2217/fmb-2020-0084
6
Yu Sasaki, Yasuhiko Abe, Masakuni Shoji, Naoko Mizumoto, Hiroaki Takeda, Harufumi Oizumi, Takao Yaoita, Norie Sawada, Kazumasa Yamagishi, Eiko Saito, Masafumi Watanabe, Kenichi Ishizawa, Tsuneo Konta, Takamasa Kayama, Shoichiro Tsugane, Yoshiyuki Ueno, Manami Inoue. Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort studyScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95124-1
7
Irena Mladenova. Clinical Relevance of Helicobacter pylori InfectionJournal of Clinical Medicine 2021; 10(16): 3473 doi: 10.3390/jcm10163473
8
Rocío Bonoso Criado, Laura Pérez Citores, Antonio Germán Pérez-Millán, Ángela Martina Montero Moretón, Elena González De Castro, Luis Cabezudo Molleda, María Antonia García Castro, Bruno Antonio Moreira Da Silva, Sergio Maestro Antolín, Fernando Santos Santamarta, Javier Barcenilla Laguna. PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA�Revista Española de Enfermedades Digestivas 2020;  doi: 10.17235/reed.2020.7395/2020
9
Suthathip Kittisenachai, Panadda Rojpibulstit, Ratha-Korn Vilaichone, Pornpen Gamnarai, Narumon Phaonakrop, Nuchanart Suealek, Denise Monack. FBPAII and rpoBC, the Two Novel Secreted Proteins Identified by the Proteomic Approach from a Comparative Study between Antibiotic-Sensitive and Antibiotic-Resistant Helicobacter pylori-Associated Gastritis StrainsInfection and Immunity 2021; 89(6) doi: 10.1128/IAI.00053-21
10
Hiroyuki Eto, Sho Suzuki, Chika Kusano, Hisatomo Ikehara, Ryoji Ichijima, Hirotaka Ito, Koichi Kawabe, Masashi Kawamura, Yoshioki Yoda, Moriyasu Nakahara, Takuji Gotoda. Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy Helicobacter 2021; 26(2) doi: 10.1111/hel.12788
11
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in MéxicoFrontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
12
Paula Roszczenko-Jasińska, Marta Ilona Wojtyś, Elżbieta K. Jagusztyn-Krynicka. Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targetsApplied Microbiology and Biotechnology 2020; 104(23): 9891 doi: 10.1007/s00253-020-10945-w
13
Mahdieh Yarmohammadi, Abbas Yadegar, Maryam Tajabadi Ebrahimi, Mohammad Reza Zali. Effects of a Potential Probiotic Strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-Induced Inflammatory Response and Gene Expression in Coinfected Gastric Epithelial CellsProbiotics and Antimicrobial Proteins 2021; 13(3): 751 doi: 10.1007/s12602-020-09721-z
14
Ali Bin-Hameed Eidha, Mohammed Barajash Huda. Screening for the prevalence of Helicobacter pylori infection among dyspeptic patients using simple fecal antigen and serum antibody diagnostic methods at Mukalla city Hospitals, Hadhramout, YemenAfrican Journal of Microbiology Research 2021; 15(6): 325 doi: 10.5897/AJMR2020.9413
15
Marta Ilona Wojtyś, Radosław Jaźwiec, Saša Kazazić, Ivana Leščić Ašler, Petar Knežević, Verica Aleksić Sabo, Marija Luić, Elżbieta Katarzyna Jagusztyn-Krynicka, Agnieszka Bzowska. A comprehensive method for determining cellular uptake of purine nucleoside phosphorylase and adenylosuccinate synthetase inhibitors by H. pyloriApplied Microbiology and Biotechnology 2021; 105(20): 7949 doi: 10.1007/s00253-021-11510-9
16
Xin-Yi Feng, Yun Zhang, Bin Deng. Progress in research of high-dose dual therapy as an eradication protocol for Helicobacter pylori infectionWorld Chinese Journal of Digestology 2020; 28(17): 847 doi: 10.11569/wcjd.v28.i17.847
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
17
Heena Tabassum, Iffat Zareen Ahmad. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from Nigella sativa L. that Inhibit Cag A and Vac A Oncoprotein of Helicobacter pylori: Probable Treatment of H. pylori InfectionsMedicinal Chemistry 2020; 17(2): 146 doi: 10.2174/1573406416666200302113729
18
Junfei Ma, Jingxuan Qiu, Shuying Wang, Qianyu Ji, Dongpo Xu, Haiwang Wang, Zhiguang Wu, Qing Liu. A Novel Design of Multi-epitope Vaccine Against Helicobacter pylori by Immunoinformatics ApproachInternational Journal of Peptide Research and Therapeutics 2021; 27(2): 1027 doi: 10.1007/s10989-020-10148-x
19
Shubha Bhat, David Nunes. Pharmacist-Managed Helicobacter pylori Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World ExperiencesAnnals of Pharmacotherapy 2021; : 106002802110215 doi: 10.1177/10600280211021501
20
Xiao-Hua Li, Yong-Yi Huang, Lin-Ming Lu, Li-Juan Zhao, Xian-Ke Luo, Ru-Jia Li, Yuan-Yuan Dai, Chun Qin, Yan-Qiang Huang, Hao Chen. Early genetic diagnosis of clarithromycin resistance in <i>Helicobacter pylori</i>World Journal of Gastroenterology 2021; 27(24): 3595-3608 doi: 10.3748/wjg.v27.i24.3595